| Pentanal | Experimental | ZNF865 | 100507290 |
downregulated | pentanal results in decreased expression of ZNF865 mRNA | 19q13.42 | |
| Pentanal | Experimental | ZNF880 | 400713 |
upregulated | pentanal results in increased expression of ZNF880 mRNA | 19q13.41 | |
| Pentanal | Experimental | ZNRF2P1 | 441208 |
downregulated | pentanal results in decreased expression of ZNRF2P1 mRNA | 7p14.3 | |
| Pentanal | Experimental | ZPBP | 11055 |
upregulated | pentanal results in increased expression of ZPBP mRNA | 7p12.2 | |
| Pentanal | Experimental | ZRANB1 | 54764 |
downregulated | pentanal results in decreased expression of ZRANB1 mRNA | 10q26.13 | |
| Pentanal | Experimental | ZSCAN16-AS1 | 100129195 |
downregulated | pentanal results in decreased expression of ZSCAN16-AS1 mRNA | 6p22.1 | |
| Pentanal | Experimental | ZSCAN20 | 7579 |
downregulated | pentanal results in decreased expression of ZSCAN20 mRNA | 1p35.1 | |
| Pentanal | Experimental | ZSCAN25 | 221785 |
downregulated | pentanal results in decreased expression of ZSCAN25 mRNA | 7q22.1 | |
| Pentanal | Experimental | ZSWIM5 | 57643 |
downregulated | pentanal results in decreased expression of ZSWIM5 mRNA | 1p34.1 | |
| Pentanal | Experimental | ZXDC | 79364 |
downregulated | pentanal results in decreased expression of ZXDC mRNA | 3q21.3 | |
| Pentoxifylline | Approved Investigational | BCL2L1 | 598 |
downregulated | Pentoxifylline results in decreased expression of BCL2L1 mRNA | 20q11.21 | |
| Pentoxifylline | Approved Investigational | FAS | 355 |
upregulated | Pentoxifylline results in increased expression of FAS mRNA | 10q23.31 | |
| Pentoxifylline | Approved Investigational | FOS | 2353 |
upregulated | Pentoxifylline results in increased expression of FOS mRNA | 14q24.3 | |
| Pentoxifylline | Approved Investigational | GADD45A | 1647 |
upregulated | Pentoxifylline results in increased expression of GADD45A mRNA | 1p31.3 | |
| Pentoxifylline | Approved Investigational | IL2RA | 3559 |
downregulated | Pentoxifylline results in decreased expression of IL2RA mRNA | 10p15.1 | |
| Pentoxifylline | Approved Investigational | MCL1 | 4170 |
upregulated | Pentoxifylline results in increased expression of MCL1 mRNA | 1q21.2 | |
| Pentoxifylline | Approved Investigational | TNF | 7124 |
downregulated | Pentoxifylline results in decreased expression of TNF mRNA | 6p21.33 | |
| Pentoxifylline | Approved Investigational | TNFSF10 | 8743 |
upregulated | Pentoxifylline results in increased expression of TNFSF10 mRNA | 3q26 | |
| Perflubron | Investigational | CYP11A1 | 1583 |
upregulated | perflubron results in increased expression of CYP11A1 mRNA | 15q24.1 | |
| Perflubron | Investigational | CYP11B1 | 1584 |
upregulated | perflubron results in increased expression of CYP11B1 mRNA | 8q24.3 | |
| Perflubron | Investigational | CYP11B2 | 1585 |
upregulated | perflubron results in increased expression of CYP11B2 mRNA | 8q24.3 | |
| Perflubron | Investigational | CYP17A1 | 1586 |
upregulated | perflubron results in increased expression of CYP17A1 mRNA | 10q24.32 | |
| Perflubron | Investigational | CYP19A1 | 1588 |
upregulated | perflubron results in increased expression of CYP19A1 mRNA | 15q21.2 | |
| Perflubron | Investigational | CYP21A2 | 1589 |
upregulated | perflubron results in increased expression of CYP21A2 mRNA | 6p21.33 | |
| Perflubron | Investigational | HMGCR | 3156 |
upregulated | perflubron results in increased expression of HMGCR mRNA | 5q13.3 | |